BG107473A - Хранителен състав - Google Patents

Хранителен състав Download PDF

Info

Publication number: BG107473A
Authority: BG; Bulgaria
Prior art keywords: composition according; composition; health; pathogenic bacteria; fiber
Prior art date: 2000-07-24

Application number

BG107473A

Other languages

Bulgarian (bg)

English (en)

Inventor

Florence Rochat

Olivier Ballevre

Alfred Jann

Original Assignee

Societe Des Produits Nestle S.А.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-24

Filing date

2003-01-17

Publication date

2004-07-30

2003-01-17 Application filed by Societe Des Produits Nestle S.А. filed Critical Societe Des Produits Nestle S.А.

2004-07-30 Publication of BG107473A publication Critical patent/BG107473A/bg

Links

239000000203 mixture Substances 0.000 title claims abstract description 73
235000016709 nutrition Nutrition 0.000 title claims abstract description 16
150000001720 carbohydrates Chemical class 0.000 claims abstract description 37
235000014633 carbohydrates Nutrition 0.000 claims abstract description 36
244000052616 bacterial pathogen Species 0.000 claims abstract description 17
230000036541 health Effects 0.000 claims abstract description 16
208000015181 infectious disease Diseases 0.000 claims abstract description 15
238000004519 manufacturing process Methods 0.000 claims abstract description 13
238000000034 method Methods 0.000 claims abstract description 10
235000013376 functional food Nutrition 0.000 claims abstract description 9
239000003814 drug Substances 0.000 claims abstract description 8
230000002265 prevention Effects 0.000 claims abstract description 7
230000002195 synergetic effect Effects 0.000 claims abstract description 7
239000011347 resin Substances 0.000 claims description 18
229920005989 resin Polymers 0.000 claims description 18
230000009286 beneficial effect Effects 0.000 claims description 16
230000000694 effects Effects 0.000 claims description 14
239000000835 fiber Substances 0.000 claims description 11
229920002472 Starch Polymers 0.000 claims description 10
239000008107 starch Substances 0.000 claims description 10
235000019698 starch Nutrition 0.000 claims description 10
FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 8
229940107187 fructooligosaccharide Drugs 0.000 claims description 8
208000002551 irritable bowel syndrome Diseases 0.000 claims description 8
235000010643 Leucaena leucocephala Nutrition 0.000 claims description 7
229940079593 drug Drugs 0.000 claims description 6
235000021197 fiber intake Nutrition 0.000 claims description 5
229920001202 Inulin Polymers 0.000 claims description 4
241001465754 Metazoa Species 0.000 claims description 4
HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
229940029339 inulin Drugs 0.000 claims description 4
230000002085 persistent effect Effects 0.000 claims description 4
235000007542 Cichorium intybus Nutrition 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
208000024891 symptom Diseases 0.000 claims description 2
241000220479 Acacia Species 0.000 claims 3
241000723343 Cichorium Species 0.000 claims 1
241000186000 Bifidobacterium Species 0.000 abstract description 24
210000001035 gastrointestinal tract Anatomy 0.000 abstract description 6
210000000936 intestine Anatomy 0.000 abstract description 3
230000001737 promoting effect Effects 0.000 abstract 4
241000894006 Bacteria Species 0.000 description 9
230000008901 benefit Effects 0.000 description 9
210000003608 fece Anatomy 0.000 description 8
239000003925 fat Substances 0.000 description 6
235000019197 fats Nutrition 0.000 description 6
230000000968 intestinal effect Effects 0.000 description 6
239000000047 product Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
241000283707 Capra Species 0.000 description 5
230000009467 reduction Effects 0.000 description 5
235000021391 short chain fatty acids Nutrition 0.000 description 5
150000004666 short chain fatty acids Chemical class 0.000 description 5
240000007472 Leucaena leucocephala Species 0.000 description 4
235000005911 diet Nutrition 0.000 description 4
230000037213 diet Effects 0.000 description 4
235000013305 food Nutrition 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
235000018102 proteins Nutrition 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
108010010256 Dietary Proteins Proteins 0.000 description 3
102000015781 Dietary Proteins Human genes 0.000 description 3
235000010469 Glycine max Nutrition 0.000 description 3
235000009508 confectionery Nutrition 0.000 description 3
235000021245 dietary protein Nutrition 0.000 description 3
210000000987 immune system Anatomy 0.000 description 3
235000020183 skimmed milk Nutrition 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
235000017060 Arachis glabrata Nutrition 0.000 description 2
244000105624 Arachis hypogaea Species 0.000 description 2
235000010777 Arachis hypogaea Nutrition 0.000 description 2
235000018262 Arachis monticola Nutrition 0.000 description 2
241000193468 Clostridium perfringens Species 0.000 description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
244000068988 Glycine max Species 0.000 description 2
108010011756 Milk Proteins Proteins 0.000 description 2
102000014171 Milk Proteins Human genes 0.000 description 2
108010073771 Soybean Proteins Proteins 0.000 description 2
230000003187 abdominal effect Effects 0.000 description 2
235000013361 beverage Nutrition 0.000 description 2
235000013325 dietary fiber Nutrition 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
230000008821 health effect Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000000787 lecithin Substances 0.000 description 2
235000010445 lecithin Nutrition 0.000 description 2
235000021239 milk protein Nutrition 0.000 description 2
235000020232 peanut Nutrition 0.000 description 2
239000000843 powder Substances 0.000 description 2
229940001941 soy protein Drugs 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
235000013618 yogurt Nutrition 0.000 description 2
DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
241000209763 Avena sativa Species 0.000 description 1
235000007558 Avena sp Nutrition 0.000 description 1
102000011632 Caseins Human genes 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
244000298479 Cichorium intybus Species 0.000 description 1
241000193163 Clostridioides difficile Species 0.000 description 1
244000124209 Crocus sativus Species 0.000 description 1
235000015655 Crocus sativus Nutrition 0.000 description 1
108010082495 Dietary Plant Proteins Proteins 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
241000305071 Enterobacterales Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
229920002907 Guar gum Polymers 0.000 description 1
241000186660 Lactobacillus Species 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
108010070551 Meat Proteins Proteins 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
206010000059 abdominal discomfort Diseases 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000001785 acacia senegal l. willd gum Substances 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
235000012182 cereal bars Nutrition 0.000 description 1
230000008859 change Effects 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000015140 cultured milk Nutrition 0.000 description 1
238000013461 design Methods 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000002550 fecal effect Effects 0.000 description 1
235000003084 food emulsifier Nutrition 0.000 description 1
230000006870 function Effects 0.000 description 1
235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
150000003271 galactooligosaccharides Chemical class 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000000665 guar gum Substances 0.000 description 1
235000010417 guar gum Nutrition 0.000 description 1
229960002154 guar gum Drugs 0.000 description 1
230000007407 health benefit Effects 0.000 description 1
230000003862 health status Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000008101 lactose Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
235000014666 liquid concentrate Nutrition 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000021243 milk fat Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
235000014594 pastries Nutrition 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
239000004248 saffron Substances 0.000 description 1
235000013974 saffron Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000035807 sensation Effects 0.000 description 1
235000011888 snacks Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
238000012384 transportation and delivery Methods 0.000 description 1
235000019871 vegetable fat Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
235000021119 whey protein Nutrition 0.000 description 1
235000008939 whole milk Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Botany (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Grain Derivatives (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Feed For Specific Animals (AREA)
Fodder In General (AREA)

BG107473A 2000-07-24 2003-01-17 Хранителен състав BG107473A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00115850A EP1175905A1 (en)	2000-07-24	2000-07-24	Nutritional Composition
PCT/EP2001/008283 WO2002007533A2 (en)	2000-07-24	2001-07-17	Nutritional composition

Publications (1)

Publication Number	Publication Date
BG107473A true BG107473A (bg)	2004-07-30

Family

ID=8169332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG107473A BG107473A (bg)	2000-07-24	2003-01-17	Хранителен състав

Country Status (22)

Country	Link
US (2)	US20030166610A1 (pt)
EP (4)	EP1175905A1 (pt)
JP (1)	JP4955896B2 (pt)
KR (1)	KR20030041962A (pt)
CN (1)	CN100349575C (pt)
AT (1)	ATE485827T1 (pt)
AU (1)	AU2001289680A1 (pt)
BG (1)	BG107473A (pt)
BR (2)	BRPI0112685B1 (pt)
CA (1)	CA2416990C (pt)
CZ (1)	CZ2003535A3 (pt)
DE (1)	DE60143356D1 (pt)
DK (1)	DK1305036T3 (pt)
ES (2)	ES2355754T3 (pt)
HU (1)	HUP0303728A3 (pt)
IL (1)	IL153989A (pt)
MX (1)	MXPA03000742A (pt)
NO (1)	NO20030316L (pt)
PL (1)	PL366049A1 (pt)
PT (1)	PT1305036E (pt)
WO (1)	WO2002007533A2 (pt)
ZA (1)	ZA200301401B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2815824B1 (fr) *	2000-10-31	2003-04-25	Colloides Naturels Internat	Methode et preparation de type fibre alimentaire soluble bifidogene pour la mise en oeuvre de ladite methode
JP2004537325A (ja)	2001-08-20	2004-12-16	カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント	非澱粉多糖類
GB0229015D0 (en)	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
FR2848783B1 (fr) *	2002-12-18	2005-05-13	Agronomique Inst Nat Rech	Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant
HRP20150037T4 (hr)	2003-04-08	2022-09-02	Progenics Pharmaceuticals, Inc.	Farmaceutske formulacije koje sadrže metilnaltrekson
DK1675481T3 (da) *	2003-10-24	2009-01-19	Nutricia Nv	Synbiotisk præparat til börn
NO320546B1 (no) *	2003-12-12	2005-12-19	Nova Biotics As	Prebiotiske kombinasjonsprodukter
US8148351B2 (en)	2003-12-12	2012-04-03	Taiyo Kagaku Co., Ltd.	Enteropathy ameliorating composition
WO2006012536A2 (en)	2004-07-22	2006-02-02	Ritter Andrew J	Methods and compositions for treating lactose intolerance
AU2006217160B2 (en)	2005-02-28	2011-09-15	N.V. Nutricia	Nutritional composition with probiotics
ES2714198T3 (es)	2005-03-07	2019-05-27	Univ Chicago	Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US9662325B2 (en)	2005-03-07	2017-05-30	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en)	2005-03-07	2013-08-27	The University Of Chicago	Use of opioid antagonists
US8524731B2 (en)	2005-03-07	2013-09-03	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es)	2005-05-25	2007-11-28	Progenics Pharm Inc	Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
GB2432772B (en) *	2005-11-30	2011-06-01	Sis	Improvements in and relating to nutritional products
TWI489984B (zh)	2006-08-04	2015-07-01	Wyeth Corp	用於非經腸道傳輸化合物之配方及其用途
CL2008000905A1 (es)	2007-03-29	2008-08-22	Progenics Pharm Inc	Compuestos derivados de morfina, antagonistas del receptor opioide periferico; metodo de preparacion; composicion farmaceutica; y uso para reducir los efectos de la actividad opioide endogena.
SI2565195T1 (sl)	2007-03-29	2015-09-30	Wyeth Llc	Periferalni opioidni receptorji in antagonisti in njih uporaba
MX2009010550A (es)	2007-03-29	2009-12-14	Progenics Pharm Inc	Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
GB0718974D0 (en)	2007-09-28	2007-11-07	Univ Leuven Kath	oligosaccharides derived from arabinoxylan for prevention of gastrointestinal infection
CN101945589A (zh) *	2007-12-21	2011-01-12	荷兰纽迪希亚公司	用于改善肠道微生物群的非消化性碳水化合物的用途
EP2240489A1 (en)	2008-02-06	2010-10-20	Progenics Pharmaceuticals, Inc.	Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
EP2278966B1 (en)	2008-03-21	2019-10-09	The University of Chicago	Treatment with opioid antagonists and mtor inhibitors
GB0805360D0 (en)	2008-03-25	2008-04-30	Univ Leuven Kath	Arabinoxylan oligosaccharide preparation
US9414621B2 (en)	2008-03-28	2016-08-16	Nestec S.A.	Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
WO2010008272A1 (en) *	2008-07-15	2010-01-21	N.V. Nutricia	Treatment of gut motility disorders
CA2676881C (en)	2008-09-30	2017-04-25	Wyeth	Peripheral opioid receptor antagonists and uses thereof
SG173832A1 (en)	2009-02-24	2011-09-29	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
BR112012011294B1 (pt)	2009-11-12	2018-03-20	Nestec S.A.	Composição nutricional para administração a um indivíduo
EP2563372A4 (en)	2010-04-28	2013-10-02	Ritter Pharmaceuticals Inc	PREBIOTIC FORMULATIONS AND METHODS OF USE
KR101421807B1 (ko) *	2012-09-28	2014-07-22	주식회사 포스코	코크스 오븐의 타르 제거장치
US20150296851A1 (en) *	2012-11-27	2015-10-22	Shanghai Jiao Tong University	Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
CN103704472B (zh) *	2013-12-13	2016-03-23	山东星光生物科技有限公司	一种低聚果糖功能性浓缩饲料及其制备方法
CA2930348C (en)	2013-12-20	2023-03-07	Nestec S.A.	Nutritional compositions for reducing intestinal pathogens
CN104920809B (zh) *	2014-03-18	2018-02-23	中国科学院大连化学物理研究所	一种改善母猪奶水中乳汁寡糖的饲料添加剂预混剂及其使用方法
WO2015162447A1 (en) *	2014-04-25	2015-10-29	Nexira International	Use of a composition comprising arabic gum (ag) for improving gut impermeability
JP6688736B2 (ja) *	2014-10-03	2020-04-28	株式会社明治	オリゴ糖製剤及びその製造方法
CN104939082A (zh) *	2015-06-02	2015-09-30	西安膳方医药科技有限公司	一种复合益生元及其制备方法
US20190000873A1 (en) *	2015-08-04	2019-01-03	Südzucker AG	Prophylactic use of inulin against sinusitis
CA2995347A1 (en) *	2015-08-11	2017-02-16	Shaklee Corporation	Materials and methods for improving gastrointestinal health
TW201826948A (zh) *	2017-01-13	2018-08-01	美商通路實業集團國際公司	膳食益生增補品及其相關方法
CN108902970A (zh) *	2018-06-27	2018-11-30	安徽瑞康食品生物科技有限公司	含有戊聚糖的食用组合物，功能食品及其制备方法、用途
CN109315728A (zh) *	2018-09-19	2019-02-12	北京爱仁医疗科技有限公司	一种含有虾青素的食品及其在肠道菌群调节中的应用
WO2022083858A1 (en) *	2020-10-21	2022-04-28	Compagnie Gervais Danone	Acacia gum for iron induced microbial dysbiosis
AU2022373326A1 (en) *	2021-10-22	2024-05-02	Mars, Incorporated	Nucleotides and oligosaccharides for use as food composition
JP7513327B1 (ja)	2023-09-01	2024-07-09	株式会社feileB	固形製剤
EP4559326A1 (en) *	2023-11-23	2025-05-28	Rudjer Boskovic Institute	Nutritional composition comprising curcumin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5444054A (en) *	1994-04-01	1995-08-22	Abbott Labatories	Method of treating ulcerative colitis
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
ES2123903T5 (es) *	1995-08-04	2011-02-22	N.V. Nutricia	Composición nutritiva conteniendo fibra.
CA2198681C (en) *	1996-03-01	2004-10-26	Sherianne James	Method for producing fat-free and low-fat viscous dressings using inulin
US5952033A (en) *	1996-12-24	1999-09-14	Nestec S.A.	Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
IT1304170B1 (it) *	1998-12-15	2001-03-08	Novartis Nutrition Ag	Composti organici
JP4273277B2 (ja) *	1999-06-30	2009-06-03	大塚製薬株式会社	オリゴ糖補給組成物

2000
- 2000-07-24 EP EP00115850A patent/EP1175905A1/en not_active Withdrawn
2001
- 2001-07-17 DK DK01969415.7T patent/DK1305036T3/da active
- 2001-07-17 EP EP01969415A patent/EP1305036B1/en not_active Expired - Lifetime
- 2001-07-17 CZ CZ2003535A patent/CZ2003535A3/cs unknown
- 2001-07-17 KR KR10-2003-7001016A patent/KR20030041962A/ko not_active Withdrawn
- 2001-07-17 BR BRPI0112685A patent/BRPI0112685B1/pt unknown
- 2001-07-17 AT AT01969415T patent/ATE485827T1/de active
- 2001-07-17 HU HU0303728A patent/HUP0303728A3/hu unknown
- 2001-07-17 CN CNB018161537A patent/CN100349575C/zh not_active Expired - Fee Related
- 2001-07-17 CA CA2416990A patent/CA2416990C/en not_active Expired - Lifetime
- 2001-07-17 PL PL01366049A patent/PL366049A1/xx not_active Application Discontinuation
- 2001-07-17 MX MXPA03000742A patent/MXPA03000742A/es unknown
- 2001-07-17 ES ES01969415T patent/ES2355754T3/es not_active Expired - Lifetime
- 2001-07-17 AU AU2001289680A patent/AU2001289680A1/en not_active Abandoned
- 2001-07-17 IL IL15398901A patent/IL153989A/xx not_active IP Right Cessation
- 2001-07-17 DE DE60143356T patent/DE60143356D1/de not_active Expired - Lifetime
- 2001-07-17 ES ES10176464.5T patent/ES2650122T3/es not_active Expired - Lifetime
- 2001-07-17 EP EP10176464.5A patent/EP2255815B1/en not_active Expired - Lifetime
- 2001-07-17 WO PCT/EP2001/008283 patent/WO2002007533A2/en not_active Ceased
- 2001-07-17 PT PT01969415T patent/PT1305036E/pt unknown
- 2001-07-17 JP JP2002513286A patent/JP4955896B2/ja not_active Expired - Fee Related
- 2001-07-17 BR BR0112685-7A patent/BR0112685A/pt not_active IP Right Cessation
- 2001-07-17 EP EP10161205A patent/EP2204176A3/en not_active Withdrawn
2003
- 2003-01-17 BG BG107473A patent/BG107473A/bg unknown
- 2003-01-21 NO NO20030316A patent/NO20030316L/no unknown
- 2003-01-24 US US10/350,092 patent/US20030166610A1/en not_active Abandoned
- 2003-02-20 ZA ZA200301401A patent/ZA200301401B/en unknown
2004
- 2004-09-16 US US10/942,722 patent/US7141554B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4955896B2 (ja)	2012-06-20
DE60143356D1 (de)	2010-12-09
AU2001289680A1 (en)	2002-02-05
PT1305036E (pt)	2011-01-28
NO20030316L (no)	2003-03-14
PL366049A1 (en)	2005-01-24
IL153989A (en)	2005-08-31
WO2002007533A3 (en)	2002-04-11
HUP0303728A2 (hu)	2004-03-29
WO2002007533A2 (en)	2002-01-31
ZA200301401B (en)	2004-05-21
CA2416990A1 (en)	2002-01-31
CA2416990C (en)	2010-09-14
EP2204176A2 (en)	2010-07-07
EP2255815A2 (en)	2010-12-01
BRPI0112685B1 (pt)	2020-04-07
EP2255815A3 (en)	2012-07-11
DK1305036T3 (da)	2011-02-07
BR0112685A (pt)	2003-06-24
HUP0303728A3 (en)	2004-12-28
CN100349575C (zh)	2007-11-21
EP1175905A1 (en)	2002-01-30
CN1466459A (zh)	2004-01-07
EP1305036A2 (en)	2003-05-02
MXPA03000742A (es)	2003-09-25
ATE485827T1 (de)	2010-11-15
US20030166610A1 (en)	2003-09-04
JP2004504332A (ja)	2004-02-12
US7141554B2 (en)	2006-11-28
ES2650122T3 (es)	2018-01-17
IL153989A0 (en)	2003-07-31
US20050053641A1 (en)	2005-03-10
CZ2003535A3 (cs)	2003-09-17
EP2255815B1 (en)	2017-10-25
NO20030316D0 (no)	2003-01-21
ES2355754T3 (es)	2011-03-30
EP2204176A3 (en)	2010-07-14
EP1305036B1 (en)	2010-10-27
KR20030041962A (ko)	2003-05-27

Publication	Publication Date	Title
BG107473A (bg)	2004-07-30	Хранителен състав
JP4793533B2 (ja)	2011-10-12	ポリデキストロースでの免疫系の刺激
CN103653170A (zh)	2014-03-26	一种水苏糖益生菌固体饮料
US20210360958A1 (en)	2021-11-25	Sleep-improving compositions
WO2022266058A1 (en)	2022-12-22	Methods and compositions for treating gas
Khan et al.	2024	Effect Of Supplementation Of Β-Galacto-Oligosaccharide And Probiotic Mixture On Growth Performance Of Physiologically Stressed Rabbits
CN1889964B (zh)	2011-06-08	用于改善肠疾病的组合物
RU2721257C2 (ru)	2020-05-18	Питательные композиции и детские смеси, содержащие олигофруктозу, для снижения нагрузки патогенных бактерий в кишечнике младенцев и детей младшего возраста
JPH06135838A (ja)	1994-05-17	経口経管栄養組成物
KR20060024766A (ko)	2006-03-17	혈중 저분자량질소함유화합물의 농도를 저감시키는질병개선용식품
US6488969B1 (en)	2002-12-03	Method for reducing blood ammonia concentration
CN116173076A (zh)	2023-05-30	一种护肝解酒的组合物及其应用
RU2096974C1 (ru)	1997-11-27	Способ коррекции углеводного состава пищевых продуктов общего и специального назначения (варианты)
JP3749647B2 (ja)	2006-03-01	血中アンモニア低減剤
JPH10179087A (ja)	1998-07-07	肝疾患患者用食品組成物
WO2025049896A1 (en)	2025-03-06	Methods of reversing oxidative stress with lactulose and other prebiotic compounds
Nielsen	0	Evaluation of whey permeate in the treatment of moderate malnutrition
US20020197342A1 (en)	2002-12-26	Method of wound healing
CN121078987A (zh)	2025-12-05	用于个体的组合物
KR20140006004A (ko)	2014-01-15	장 통과 조절 효과를 제공하기 위한 갈락토프룩토오스